Search Results
- < Prev
1 of 1
- Next >
News Releases
-
Apr 24, 2013, 09:00 ET
Research Foundations Collaborate To Fund Phase 1 Study Of Cancer Drug In Alzheimer's Disease Patients
The Alzheimer's Drug Discovery Foundation (ADDF) and BrightFocus Foundation today announced a funding collaboration that will support a Phase I human clinical trial to evaluate the cancer drug bexarotene as a treatment for Alzheimer's disease. Through this partnership, the organizations are...
More news about: Alzheimer's Drug Discovery Foundation , ReXceptor Inc. , BrightFocus Foundation
- < Prev
1 of 1
- Next >
Modify your Search
 |
Quickly search for PR Newswire releases by adding our plugin to your browser search |